Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
5.49
+0.07 (1.29%)
At close: Jun 4, 2025, 4:00 PM
5.53
+0.04 (0.73%)
After-hours: Jun 4, 2025, 7:59 PM EDT

Altimmune Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
445513604808363417
Upgrade
Market Cap Growth
-46.64%-15.16%-25.23%122.62%-12.91%1369.44%
Upgrade
Enterprise Value
297375464608165212
Upgrade
Last Close Price
5.497.2111.2516.459.1611.28
Upgrade
PS Ratio
22263.8625640.431418.90-11888.9082.3550.95
Upgrade
PB Ratio
3.014.153.114.361.821.85
Upgrade
P/TBV Ratio
3.134.153.114.681.951.96
Upgrade
EV/Sales Ratio
14851.9118760.081090.28-37.3925.91
Upgrade
Debt / Equity Ratio
0.010.010.000.010.010.01
Upgrade
Asset Turnover
000.00-0.020.06
Upgrade
Quick Ratio
15.5412.9016.6910.9910.7318.99
Upgrade
Current Ratio
15.8513.1117.2611.3111.1719.16
Upgrade
Return on Equity (ROE)
-57.28%-59.86%-46.63%-44.07%-45.69%-36.14%
Upgrade
Return on Assets (ROA)
-35.51%-36.85%-25.00%-25.73%-22.86%-16.10%
Upgrade
Return on Capital (ROIC)
-38.69%-40.31%-27.38%-28.31%-24.76%-17.52%
Upgrade
Earnings Yield
-20.27%-18.54%-14.63%-10.48%-26.74%-11.76%
Upgrade
FCF Yield
-18.04%-15.57%-12.55%-7.76%-24.88%-8.28%
Upgrade
Buyback Yield / Dilution
-23.58%-33.35%-13.47%-13.67%-61.03%-95.33%
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q